1.Studies on scavenge of hydroxyl radical and protection of DNA damage by 5 defferent Uighur medicinal herbs
Abudureyimu ; Abuduaini ; Hamulati ; Reziwanguli
Chinese Traditional and Herbal Drugs 1994;0(03):-
Object To study the hydroxyl radical scavenging and DNA damage protecting activities of 5 Uighur herbal medicines Euphorbia humifusa Willd , Borago officinalis L, Cassia angustifolia Vahl, Terminalia chebula Retz. and Fomes officinalis (Vill ex Fr ) Bres Methods The hydroxyl radical scavenging action and DNA damage protection action were determined by CuSO 4 Vit C H 2O 2 yeast and CuSO 4 Vit C H 2O 2 phen DNA chemiluminescence systems respectively Results All 5 Uighur medicinal herbs showed hydroxyl radical scavenging and DNA damage protection activities in dose dependent manners Conculsion The hydroxyl radical scavenging and DNA protective effects may possibly be the mechanisms of their antiaging and therapeutic effects against various diseases
2.Meta-analysis of the diagnostic value of the Simple Five item Scoring Scale for Sarcopenia in elderly patients with sarcopenia
Yajie CHE ; Ainiwa REZIWANGULI· ; Xuanxuan YANG ; Bing LIANG ; Ping YAN
Chinese Journal of Practical Nursing 2021;37(24):1914-1918
Objective:To evaluate the diagnostic accuracy and clinical applicability of the Simple Five item Scoring Scale for Sarcopenia (SARC-F) by systematic review and Meta-analysis.Methods:PubMed, The Cochrane Library, Wed of science, EMBASE, MEDLINE, Ovid, China HowNet database, China biomedical data, VIP database and Wanfang database were searched by computer, and all the researches related to SARC-F questionnaire's diagnosis of sarcopenia from the establishment of the database to March 1, 2020 were collected. Two researchers independently selected literature, extracted data, and evaluated the bias risk of the study. Revman 5.3 software, Stata16.0software were used to comprehensively evaluate the diagnostic value of SARC-F questionnaire for sarcopenia.Results:A total of 13 studies involving 8 860 patients were included. The results of meta-analysis showed that the sensitivity and specificity of the diagnostic criteria established by the European Working Group of Sarcopenia, the Asian Working Group for Sarcopenia and the International Working Group for Sarcopenia were used as the gold standard. The area under the receiver operating characteristic curve was 0.71, 0.69 and 0.67 respectively, and the Q-index was 0.659 3, 0.650 9 and 0.631 6.Conclusion:SARC-F questionnaire has a certain value in the screening and diagnosis of sarcopenia. In the future research, it is suggested to add the simple measurement of muscle quality on the basis of this scale to improve the accuracy of the questionnaire screening
3.Analysis of a patient with Kallmann syndrome and a 45,X/46,XY karyotype.
Fuhui MA ; Xinling WANG ; Wusiman REZIWANGULI ; Yuan CHEN ; Yanying GUO
Chinese Journal of Medical Genetics 2022;39(11):1275-1278
OBJECTIVE:
To explore the etiology of a patient with Kallmann syndrome (congenital hypogonadism and anosmia) and a 45,X/46,XY karyotype.
METHODS:
Peripheral venous blood samples were collected from the proband and his parents and subjected to whole exome sequencing. Candidate variants were verified by Sanger sequencing.
RESULTS:
The proband was found to harbor compound heterozygous variants of the PROKR2 gene, namely c.533G>C (p.W178S) and c.308C>T (p.A103V), which were inherited from his father and mother, respectively. The two variants were respectively predicted to be likely pathogenic and variant of unknown significance, respectively.
CONCLUSION
The reduced chromosomal mosaicism might have caused no particular clinical manifestations in this patient. For patients with features of Kallmann syndrome, genetic testing is conducive to early diagnosis and can provide a basis for genetic counseling and clinical treatment.
Humans
;
Genetic Testing
;
Hypogonadism/genetics*
;
Kallmann Syndrome/genetics*
;
Karyotype
;
Mutation
;
Exome Sequencing
;
Chromosomes, Human, X/genetics*
;
Chromosomes, Human, Y/genetics*
4. Effects of different doses of dexmedetomidine on non-cardiac surgery stress and postoperative sleep in patients with coronary heart disease
Lei YAN ; Haibin JIANG ; Paerhati NAFEISHA ; Yikemu REZIWANGULI ; Boyu GENG ; Maimaitiaili MAIERHABA
Chinese Journal of Clinical Pharmacology and Therapeutics 2022;27(12):1340-1346
AIM: To investigate the effects of different doses of degmedetomidine on stress and postoperative sleep in patients with coronare heart disease (CHD). METHODS: Sigte patients with coronare heart disease undergoing endoscopic abdominal surgere were randomle divided into three groups (n d 20): low-dose group (D1), high-dose degmedetomidine group (D2) and control group (C) In groups D1 and D2, a loading dose of degmedetomidine (0.5 μg/kg) was injected with intravenous pump for 10 min, followed be the maintain dose of degmedetomidine 0.2 and 0.6 μg·kg